Rocio Alvarez-Marin
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Development and internal validation of a Viremia-Integrated Risk Assessment (VIRA score) for predicting mortality at diagnosis of COVID-19 pneumonia.
Journal: Pneumonia (Nathan Qld.)
Published: April 15, 2026
Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.
Journal: Lancet (London, England)
Published: January 20, 2026
Development of a Comprehensive Program for the Early Diagnosis and Treatment of Severe Infections in a Tertiary Hospital in Spain.
Journal: Open forum infectious diseases
Published: August 11, 2025
Factors associated with SARS-CoV-2 RNAemia development at COVID-19 diagnosis.
Journal: PloS one
Published: April 10, 2025
Effectiveness and safety of strategies to optimise antimicrobial use in solid organ transplant recipients. Systematic review and meta-analyses.
Journal: EClinicalMedicine
Published: January 26, 2025
COVID-19 clinical phenotypes in vaccinated and nonvaccinated solid organ transplant recipients: a multicenter validation study.
Journal: Scientific reports
Published: June 04, 2024
COVID-19 in patients with haematologic malignancies: Effect of RNAemia on clinical outcome in vaccinated patients.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: March 04, 2024
Antimicrobial Stewardship in the Emergency Department Observation Unit: Definition of a New Indicator and Evaluation of Antimicrobial Use and Clinical Outcomes.
Journal: Antibiotics (Basel, Switzerland)
Published: February 22, 2024
Role of blaTEM and OmpC in the piperacillin-tazobactam resistance evolution by E. coli in patients with complicated intra-abdominal infection.
Journal: The Journal of infection
Published: April 20, 2023
Serum IFN-γ and RNAemia temporal profiles as biomarkers of severe COVID-19 in solid organ transplant and immunocompetent patients.
Journal: The Journal of infection
Published: January 13, 2023
Study protocol for a randomized clinical trial to assess 7 versus 14-days of treatment for Pseudomonas aeruginosa bloodstream infections (SHORTEN-2 trial).
Journal: PloS one
Published: October 11, 2022
Carbapenem Combinations for Infections Caused by Carbapenemase-Producing Pseudomonas aeruginosa: Experimental In Vitro and In Vivo Analysis.
Journal: Antibiotics (Basel, Switzerland)
Published: August 17, 2022
Last Updated: 09/26/2026